Valtech Cardio

http://www.valtechcardio.com/

Last activity: 28.11.2016

Active - Reference to Edwards Lifesciences

Categories: AssuranceDevelopmentHardwareManufacturingProductResearch

Valtech Cardio Ltd., develops devices for the treatment of mitral valve regurgitation (MR), the most common heart valve disease. The company develops a range of products for transcatheter valve repair and replacement, based on the surgical gold standard, as well as repair products for open heart surgery that enable fine tuning on a beating heart.
Valtech Cardio has full in-house development, manufacturing, quality assurance and clinical research capabilities and over 130 patents and patents applications.
The company, comprised of multidisciplinary development teams, works in close collaboration with world renowned heart specialists to provide the best therapy a mitral patient can hope for.

Mentions

Overview

Employees

11-50

Founded date

2005

Mentions in press and media 2

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Feb 2, 2010	Israel, Valtech Cardio Completes $17.8M Series B Financing	Valtech Cardio Ltd., a developer of minimally-invasive surgical and transcatheter mitral valve repair and replacement technologies, completed a $17.8m Series B financing. Investors in the round included OXO Capital Valve Ventures LLC, NGN B...

Reviews 0

FAQ about Valtech Cardio

When was Valtech Cardio founded?

Valtech Cardio was founded in 2005.

What has the press written about Valtech Cardio?

Parsers VC has collected 2 articles mentioning Valtech Cardio, among them “Israel, Valtech Cardio Completes $17.8M Series B Financing” (Feb 2, 2010).

Is Valtech Cardio still active?

Yes, Valtech Cardio is active; its latest activity on Parsers VC dates from Nov 28, 2016.